PCNA and Alzheimer disease: In concordance, the immunohistochemical analysis of AD patients showed that patients with elevated NAMPT and PAR levels (Figure 1) also had an elevated signal of the proliferation marker PCNA in the basal and spinous layer (Figure 4C).